Cognitive impairment in arterial hypertension
The article presents a current view on pathogenesis, diagnostic methods and treatment of cognitive disorders in patients with arterial hypertension. Choline alfoscerate drugs, precursors for choline drugs, are characterized. Prescription of the drugs for patients with hypertensive encephalopathy is...
| Published in: | Медицинский совет |
|---|---|
| Main Author: | |
| Format: | Article |
| Language: | Russian |
| Published: |
Remedium Group LLC
2015-12-01
|
| Subjects: | |
| Online Access: | https://www.med-sovet.pro/jour/article/view/268 |
| _version_ | 1857119088590979072 |
|---|---|
| author | M. V. Nesterova |
| author_facet | M. V. Nesterova |
| author_sort | M. V. Nesterova |
| collection | DOAJ |
| container_title | Медицинский совет |
| description | The article presents a current view on pathogenesis, diagnostic methods and treatment of cognitive disorders in patients with arterial hypertension. Choline alfoscerate drugs, precursors for choline drugs, are characterized. Prescription of the drugs for patients with hypertensive encephalopathy is discussed. Results of clinical trials of the efficacy and safety of the national choline alfoscerate under the brand name Cerepro® are demonstrated. |
| format | Article |
| id | doaj-art-e7e56cb79ebc4ab4bdc4523ea6a0040c |
| institution | Directory of Open Access Journals |
| issn | 2079-701X 2658-5790 |
| language | Russian |
| publishDate | 2015-12-01 |
| publisher | Remedium Group LLC |
| record_format | Article |
| spelling | doaj-art-e7e56cb79ebc4ab4bdc4523ea6a0040c2025-08-19T19:09:47ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902015-12-01010343810.21518/2079-701X-2015-10-34-38268Cognitive impairment in arterial hypertensionM. V. Nesterova0Ural State Medical UniversityThe article presents a current view on pathogenesis, diagnostic methods and treatment of cognitive disorders in patients with arterial hypertension. Choline alfoscerate drugs, precursors for choline drugs, are characterized. Prescription of the drugs for patients with hypertensive encephalopathy is discussed. Results of clinical trials of the efficacy and safety of the national choline alfoscerate under the brand name Cerepro® are demonstrated.https://www.med-sovet.pro/jour/article/view/268когнитивные расстройствагипертоническая энцефалопатияхолина альфосцератcognitive disordershypertensive encephalopathycholine alfoscerate |
| spellingShingle | M. V. Nesterova Cognitive impairment in arterial hypertension когнитивные расстройства гипертоническая энцефалопатия холина альфосцерат cognitive disorders hypertensive encephalopathy choline alfoscerate |
| title | Cognitive impairment in arterial hypertension |
| title_full | Cognitive impairment in arterial hypertension |
| title_fullStr | Cognitive impairment in arterial hypertension |
| title_full_unstemmed | Cognitive impairment in arterial hypertension |
| title_short | Cognitive impairment in arterial hypertension |
| title_sort | cognitive impairment in arterial hypertension |
| topic | когнитивные расстройства гипертоническая энцефалопатия холина альфосцерат cognitive disorders hypertensive encephalopathy choline alfoscerate |
| url | https://www.med-sovet.pro/jour/article/view/268 |
| work_keys_str_mv | AT mvnesterova cognitiveimpairmentinarterialhypertension |